Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Krensavage Asset Management, LLC
Form 13F · Q2 2026

Krensavage Asset Management, LLC

CIK 1609251Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$263,223
Reported book value
18
Positions
12
Quarters on record
Top 50
Positions

Krensavage Asset Management, LLC — holdings

Top 18 positions of 18, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ENTA Enanta Pharmaceuticals Inc2.9M+0.0%$41,78815.9%
2JAZZ Jazz Pharmaceuticals Plc167,816+0.0%$40,43915.4%
3UTHR United Therapeutics Corp Del69,282−17.8%$37,53914.3%
4BMRN Biomarin Pharmaceutical Inc524,786+0.0%$30,02811.4%
5EXEL Exelixis Inc370,693−10.8%$20,1697.7%
6ABT Abbott Laboratories200,000+3900.0%$18,1486.9%
7SNY Sanofi Sa323,946+0.0%$13,8205.3%
8SUPN Supernus Pharmaceuticals280,681+0.0%$13,0545.0%
9RARE Ultragenyx Pharmaceutical In390,879+0.0%$13,0515.0%
10VNDA Vanda Pharmaceuticals Inc1.2M+0.0%$7,2242.7%
11BNTX Biontech Se59,523+0.0%$5,5392.1%
12GSK Gsk Plc96,729+0.0%$5,0711.9%
13BIIB Biogen Inc20,000+0.0%$4,3211.6%
14REGN Regeneron Pharmaceuticals6,000+50.0%$3,7411.4%
15EMBC Embecta Corp1.1M+54.4%$3,7011.4%
16ARDX Ardelyx Inc534,523+6.9%$2,7261.0%
17INMD Inmode Ltd120,942+0.0%$1,7680.7%
18EOLS Evolus Inc157,985+0.0%$1,0960.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.